Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
Journal Title
Elife
Publication Type
Journal Article in press
Abstract
Many cancers overexpress one or more of the six human pro-survival BCL2 family proteins to evade apoptosis. To determine which BCL2 protein or proteins block apoptosis in different cancers, we computationally designed three-helix bundle protein inhibitors specific for each BCL2 pro-survival protein. Following in vitro optimization, each inhibitor binds its target with high picomolar to low nanomolar affinity and at least 300-fold specificity. Expression of the designed inhibitors in human cancer cell lines revealed unique dependencies on BCL2 proteins for survival which could not be inferred from other BCL2 profiling methods. Our results show that designed inhibitors can be generated for each member of a closely-knit protein family to probe the importance of specific protein-protein interactions in complex biological processes.
Publisher
elife Sciences
WEHI Research Division(s)
Molecular Genetics Of Cancer; Chemical Biology
PubMed ID
27805565
Open Access at Publisher's Site
https://elifesciences.org/content/5/e20352
NHMRC Grants
NHMRC/1024620
ARC Grants
ARC/FT150100212,
Rights Notice
Refer to copyright notice on published article.


Creation Date: 2016-11-14 11:36:19
Last Modified: 2016-11-17 11:29:36
An error has occurred. This application may no longer respond until reloaded. Reload 🗙